| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
3 |
| Product containing precisely meropenem 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely alprostadil 3 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely fosfomycin (as fosfomycin sodium) 4 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Fosfomycin (as fosfomycin sodium) 4 g powder for solution for infusion and/or injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Fosfomycin (as fosfomycin sodium) 2 g powder for solution for infusion vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely fosfomycin (as fosfomycin sodium) 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely paracetamol 1 gram/1 sachet powder for conventional release oral solution (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely ivermectin 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely hydroxocobalamin 2.5 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Glucosamine sulfate (as glucosamine sulfate sodium chloride) 1.5 g powder for oral solution sachet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely zinc undecylenate 100 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Human fibrinogen 1 g powder for solution for infusion and/or injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely permethrin 10 milligram/1 gram conventional release cutaneous solution (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely malathion 500 microgram/1 gram conventional release cutaneous emulsion (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely zinc undecylenate 100 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Diclofenac sodium 40 mg/g cutaneous spray |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Clindamycin (as clindamycin phosphate) 20 mg/g vaginal cream |
Has concentration strength denominator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Aztreonam 1 g powder for solution for infusion and/or injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Calcium carbonate 1.25 g effervescent oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely calcium carbonate 1.25 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Calcium acetate 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Calcium carbonate 1.25 g and cholecalciferol 5 microgram oral tablet |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
| Methenamine hippurate 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely methenamine mandelate 1 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Nalidixic acid 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Hydroxyurea 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Cefadroxil 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Metformin hydrochloride 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely methenamine hippurate 1 gram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Piracetam 1.2 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Levetiracetam 1 g oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely sulfalene 2 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Valacyclovir hydrochloride 1 g oral tablet |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
| Fish derived omega 3 fatty acid 1 g oral capsule |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely colestipol hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Glycerin 2 g rectal suppository |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely glycerol 4 gram/1 each conventional release rectal suppository (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely glycerol 1 gram/1 each conventional release rectal suppository (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely calcium carbonate 1.5 gram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely calcium carbonate 2.5 gram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Calcium carbonate 1.25 g chewable tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely calcium gluconate 1 gram/1 each conventional release effervescent oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Niacin 1 g prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Metformin hydrochloride 1 g prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely procainamide hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| céfazoline 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| céfradine 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
| céfotaxime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| ceftazidime 3 g, flacon de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
| céfoxitine 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| aztréonam 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| céfoxitine 2 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| aztréonam 2 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| ceftazidime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
| Cyclophosphamide (as cyclophosphamide monohydrate) 1 g powder for solution for injection vial |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
| chloramphénicol 1 g, fiole de poudre pour injection (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Deferoxamine mesylate 2 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| pénicilline G 1 200 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| ceftazidime 2 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely calcium carbonate 2.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| ceftriaxone 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| ceftriaxone 2 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| capréomycine 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| cefpirome 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| cefpirome 2 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| amoxicilline 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Ifosfamide 1 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Ifosfamide 2 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Treosulfan 5 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| méropenem 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
1 |
| floxacilline 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| érythromycine 1g, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| vancomycine 1 g, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Treosulfan 1 g powder for solution for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Mesalamine 1 g gastro-resistant and prolonged-release oral granules sachet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely codeine phosphate 60 milligram and paracetamol 1 gram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
2 |
| Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Guar gum 5 g granules for oral suspension sachet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Sodium citrate 4 g granules for oral solution sachet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely ispaghula husk 3.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Ispaghula husk 6 g powder for oral suspension sachet |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension (clinical drug) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| pipéracilline 2 g/tazobactam 250 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
False |
g |
Inferred relationship |
Some |
2 |
| pipéracilline 4 g/tazobactam 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |
| amoxicilline et clavulanate de potassium 1 mg/200 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength numerator unit |
True |
g |
Inferred relationship |
Some |
1 |